Publications of Cathelijne Frielink

Accepted or to appear

Papers in international journals

  1. I. van der Kroon, W. der Woliner-van Weg, M. Brom, L. Joosten, C. Frielink, M. Konijnenberg, E. Visser and M. Gotthardt. "Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin.". Abstract DOI PMID


2017

Papers in international journals

  1. S. Willekens, I. van der Kroon, D. Bos, L. Joosten, C. Frielink, O. Boerman, M. Brom and M. Gotthardt. "Quantitative and longitudinal imaging of intramuscular transplanted islets of Langerhans with SPECT using [ (123) I]IBZM.", 2017. Abstract DOI PMID


2016

Papers in international journals

  1. S. Willekens, I. van der Kroon, L. Joosten, C. Frielink, O. Boerman, S. van den Broek, M. Brom and M. Gotthardt. "SPECT of Transplanted Islets of Langerhans by Dopamine 2 Receptor Targeting in a Rat Model.", 2016. Abstract DOI PMID

  2. W. Eter, S. Parween, L. Joosten, C. Frielink, M. Eriksson, M. Brom, U. Ahlgren and M. Gotthardt. "SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments.", 2016. Abstract DOI PMID


2015

Papers in international journals

  1. W. Eter, D. Bos, C. Frielink, O. Boerman, M. Brom and M. Gotthardt. "Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin.", 2015. Abstract DOI PMID

  2. M. Brom, L. Joosten, C. Frielink, O. Boerman and M. Gotthardt. "111In-exendin uptake in the pancreas correlates with the beta cell mass and not with the alpha cell mass", 2015. Abstract/PDF DOI PMID

  3. C. van Rij, C. Frielink, D. Goldenberg, R. Sharkey, G. Franssen, S. Lütje, W. McBride, W. Oyen and O. Boerman. "Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-2 x Anti-HSG Bispecific Antibody in Mice with PC3 Xenografts", 2015. Abstract/PDF DOI PMID


2014

Papers in international journals

  1. C. van Rij, C. Frielink, D. Goldenberg, R. Sharkey, S. Lütje, W. McBride, W. Oyen and O. Boerman. "Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2$times$Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide", 2014. Abstract/PDF DOI PMID

  2. S. Lütje, M. Rijpkema, D. Goldenberg, C. van Rij, R. Sharkey, W. McBride, G. Franssen, C. Frielink, W. Helfrich, W. Oyen and O. Boerman. "Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer", 2014. Abstract/PDF DOI PMID

  3. M. Brom, W. der Woliner-van Weg, L. Joosten, C. Frielink, T. Bouckenooghe, P. Rijken, K. Andralojc, B. Göke, M. de Jong, D. Eizirik, M. Béhé, T. Lahoutte, W. Oyen, C. Tack, M. Janssen, O. Boerman and M. Gotthardt. "Non-invasive quantification of the beta cell mass by SPECT with (111)In-labelled exendin", 2014. Abstract/PDF DOI PMID

  4. S. Terry, K. Abiraj, C. Frielink, L. van Dijk, J. Bussink, W. Oyen and O. Boerman. "Imaging Integrin αvβ3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts", 2014. Abstract/PDF DOI PMID


2013

Papers in international journals

  1. C. van Rij, S. Lütje, C. Frielink, R. Sharkey, D. Goldenberg, G. Franssen, W. McBride, E. Rossi, W. Oyen and O. Boerman. "Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody", 2013. Abstract/PDF DOI PMID


2012

Papers in international journals

  1. A. Barradas, K. Lachmann, G. Hlawacek, C. Frielink, R. Truckenmoller, O. Boerman, R. van Gastel, H. Garritsen, M. Thomas, L. Moroni, C. van Blitterswijk and J. de Boer. "Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells", 2012. Abstract/PDF DOI PMID

  2. R. Sharkey, C. van Rij, H. Karacay, E. Rossi, C. Frielink, C. Regino, T. Cardillo, W. McBride, C. Chang, O. Boerman and D. Goldenberg. "A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers", 2012. Abstract/PDF DOI PMID


2011

Papers in international journals

  1. C. van Rij, R. Sharkey, D. Goldenberg, C. Frielink, J. Molkenboer, G. Franssen, W. van Weerden, W. Oyen and O. Boerman. "Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody", 2011. Abstract/PDF DOI PMID

  2. K. Wever, F. Wagener, C. Frielink, O. Boerman, G. Scheffer, A. Allison, R. Masereeuw and G. Rongen. "Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue", 2011. Abstract/PDF DOI PMID


2007

Papers in international journals

  1. I. Dijkgraaf, J. Kruijtzer, C. Frielink, F. Corstens, W. Oyen, R. Liskamp and O. Boerman. "Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide", 2007. Abstract DOI PMID

  2. L. de Geus-Oei, J. van Krieken, R. Aliredjo, P. Krabbe, C. Frielink, A. Verhagen, O. Boerman and W. Oyen. "Biological correlates of FDG uptake in non-small cell lung cancer", 2007. Abstract DOI PMID

  3. P. Laverman, W. Blokx, R. Te Morsche, C. Frielink, O. Boerman, W. Oyen and J. Drenth. "[(18)F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma", 2007. Abstract DOI PMID


2006

Papers in international journals

  1. M. den Brok, R. Sutmuller, S. Nierkens, E. Bennink, C. Frielink, L. Toonen, O. Boerman, C. Figdor, T. Ruers and G. Adema. "Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity", 2006. Abstract DOI PMID

  2. I. Dijkgraaf, J. Kruijtzer, C. Frielink, A. Soede, H. Hilbers, W. Oyen, F. Corstens, R. Liskamp and O. Boerman. "Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists", 2006. Abstract/PDF DOI PMID


2005

Papers in international journals

  1. F. van Schaijk, E. Oosterwijk, A. Soede, M. Broekema, C. Frielink, W. McBride, D. Goldenberg, F. Corstens and O. Boerman. "Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody", 2005. Abstract DOI PMID


2004

Papers in international journals

  1. A. Brouwers, J. van Eerd, C. Frielink, E. Oosterwijk, W. Oyen, F. Corstens and O. Boerman. "Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re", 2004. Abstract PMID

  2. M. Janssen, C. Frielink, I. Dijkgraaf, W. Oyen, D. Edwards, S. Liu, M. Rajopadhye, L. Massuger, F. Corstens and O. Boerman. "Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation", 2004. Abstract DOI PMID

  3. H. Rennen, C. Bleeker-Rovers, J. van Eerd, C. Frielink, W. Oyen, F. Corstens and O. Boerman. "99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections", 2004. Abstract DOI PMID

  4. H. Rennen, C. Frielink, E. Brandt, S. Zaat, O. Boerman, W. Oyen and F. Corstens. "Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms", 2004. Abstract PMID


2003

Papers in international journals

  1. A. Brouwers, C. Frielink, E. Oosterwijk, W. Oyen, F. Corstens and O. Boerman. "Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma", 2003. Abstract DOI PMID

  2. E. Postema, C. Frielink, W. Oyen, J. Raemaekers, D. Goldenberg, F. Corstens and O. Boerman. "Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma", 2003. Abstract DOI PMID


2002

Papers in international journals

  1. M. Janssen, W. Oyen, L. Massuger, C. Frielink, I. Dijkgraaf, D. Edwards, M. Radjopadhye, F. Corstens and O. Boerman. "Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting", 2002. Abstract DOI PMID

  2. M. Janssen, W. Oyen, I. Dijkgraaf, L. Massuger, C. Frielink, D. Edwards, M. Rajopadhye, H. Boonstra, F. Corstens and O. Boerman. "Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model", 2002. Abstract PMID